Apricell is a company spun out of the Laboratory for Innovations in Micro-Engineering at the University of Victoria, Canada. In collaboration with the University, Apricell has developed novel tumor-on-a-chip technology that opens up multiplex opportunities for researchers and oncologists all the way from basic research to patient management.